{"id":359330,"date":"2025-08-30T08:48:13","date_gmt":"2025-08-30T08:48:13","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-nuvalent\/"},"modified":"2025-08-30T08:48:13","modified_gmt":"2025-08-30T08:48:13","slug":"how-to-buy-nuvalent","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-359330","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Nuvalent, Inc. (NUVL)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Nuvalent, Inc. (NUVL)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cho danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cho danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c th\u00eam m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn v\u00e0o danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a m\u00ecnh? Nuvalent, Inc. (NUVL) \u0111\u1ea1i di\u1ec7n cho t\u01b0\u01a1ng lai c\u1ee7a \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ch\u00ednh x\u00e1c v\u1edbi danh m\u1ee5c s\u1ea3n ph\u1ea9m s\u00e1ng t\u1ea1o nh\u1eafm v\u00e0o c\u00e1c lo\u1ea1i ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y c\u00f3 th\u1ec3 l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ec3 b\u1ea1n \u0111\u1ea1t \u0111\u01b0\u1ee3c l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3 n\u1ebfu c\u00e1c li\u1ec7u ph\u00e1p c\u1ee7a h\u1ecd th\u00e0nh c\u00f4ng trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao NUVL x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh c\u1ed5 \u0111\u00f4ng.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c th\u00eam m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn v\u00e0o danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a m\u00ecnh? Nuvalent, Inc. (NUVL) \u0111\u1ea1i di\u1ec7n cho t\u01b0\u01a1ng lai c\u1ee7a \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ch\u00ednh x\u00e1c v\u1edbi danh m\u1ee5c s\u1ea3n ph\u1ea9m s\u00e1ng t\u1ea1o nh\u1eafm v\u00e0o c\u00e1c lo\u1ea1i ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb. C\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng n\u00e0y c\u00f3 th\u1ec3 l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ec3 b\u1ea1n \u0111\u1ea1t \u0111\u01b0\u1ee3c l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3 n\u1ebfu c\u00e1c li\u1ec7u ph\u00e1p c\u1ee7a h\u1ecd th\u00e0nh c\u00f4ng trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao NUVL x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh c\u1ed5 \u0111\u00f4ng."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Nuvalent: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 30 th\u00e1ng 8 n\u0103m 2025, Nuvalent, Inc. (NUVL) giao d\u1ecbch \u1edf m\u1ee9c <strong>74,93 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu tr\u00ean s\u00e0n NASDAQ. C\u1ed5 phi\u1ebfu n\u00e0y \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3, \u0111i\u1ec3n h\u00ecnh cho c\u00e1c c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng, v\u1edbi ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 55,54 USD \u0111\u1ebfn 113,51 USD - ch\u00eanh l\u1ec7ch h\u01a1n 100% gi\u1eefa m\u1ee9c th\u1ea5p v\u00e0 cao!<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 NUVL. \u0110\u00e2y l\u00e0 th\u1eddi \u0111i\u1ec3m c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3 n\u0103m 2025, v\u00e0 d\u1ef1a tr\u00ean c\u00e1c m\u1eabu l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y c\u00f3 th\u1ec3 l\u00e0m bi\u1ebfn \u0111\u1ed9ng gi\u00e1 c\u1ed5 phi\u1ebfu m\u1ea1nh m\u1ebd.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu NUVL<\/h3> <p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y cho th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng v\u1ec1 c\u00e1c bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3 quanh c\u00e1c th\u00f4ng b\u00e1o quan tr\u1ecdng:<\/p> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>7 th\u00e1ng 8, 2025<\/td><td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2<\/td><td>78,50 USD<\/td><td>-4,5% (b\u1ecf l\u1ee1 \u01b0\u1edbc t\u00ednh EPS)<\/td><\/tr> <tr><td>8 th\u00e1ng 5, 2025<\/td><td>C\u1eadp Nh\u1eadt Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/td><td>72,30 USD<\/td><td>+18,2% (d\u1eef li\u1ec7u t\u00edch c\u1ef1c)<\/td><\/tr> <tr><td>27 th\u00e1ng 2, 2025<\/td><td>K\u1ebft Qu\u1ea3 Qu\u00fd 4 n\u0103m 2024<\/td><td>68,90 USD<\/td><td>+9,8% (ti\u1ebfn tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m)<\/td><\/tr> <tr><td>9 th\u00e1ng 11, 2024<\/td><td>Tin N\u1ed9p H\u1ed3 S\u01a1 FDA<\/td><td>65,40 USD<\/td><td>+22,1% (ch\u1ea5p nh\u1eadn NDA theo t\u1eebng ph\u1ea7n)<\/td><\/tr> <tr><td>8 th\u00e1ng 8, 2024<\/td><td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2 n\u0103m 2024<\/td><td>62,10 USD<\/td><td>+11,3% (c\u1eadp nh\u1eadt danh m\u1ee5c m\u1ea1nh m\u1ebd)<\/td><\/tr> <tr><td>10 th\u00e1ng 5, 2024<\/td><td>D\u1eef Li\u1ec7u Giai \u0110o\u1ea1n 1<\/td><td>58,20 USD<\/td><td>+6,8% (k\u1ebft qu\u1ea3 kh\u00edch l\u1ec7)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: C\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c v\u1ec1 quy \u0111\u1ecbnh th\u01b0\u1eddng th\u00fac \u0111\u1ea9y m\u1ee9c t\u0103ng l\u1edbn nh\u1ea5t (18-22%), trong khi vi\u1ec7c b\u1ecf l\u1ee1 l\u1ee3i nhu\u1eadn g\u00e2y ra c\u00e1c \u0111\u1ee3t gi\u1ea3m t\u1ea1m th\u1eddi kho\u1ea3ng 4-5%. M\u00f4 h\u00ecnh n\u00e0y cho th\u1ea5y c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 NUVL n\u00ean t\u1eadp trung nhi\u1ec1u h\u01a1n v\u00e0o c\u00e1c ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng thay v\u00ec c\u00e1c b\u00e1o c\u00e1o t\u00e0i ch\u00ednh h\u00e0ng qu\u00fd.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h2> <p>C\u1ed5 phi\u1ebfu Nuvalent \u0111\u00e3 t\u0103ng <strong>27,8%<\/strong> trong s\u00e1u th\u00e1ng qua, nh\u01b0ng h\u00e0nh tr\u00ecnh kh\u00f4ng h\u1ec1 su\u00f4n s\u1ebb:<\/p> <ul> <li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 62,50 USD - Giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 sau k\u1ef3 ngh\u1ec9 l\u1ec5<\/li> <li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 71,80 USD - T\u0103ng gi\u00e1 khi b\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ALKAZAR<\/li> <li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 68,20 USD - Ch\u1ed1t l\u1eddi sau \u0111\u1ee3t t\u0103ng th\u00e1ng 3<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 83,40 USD - Tr\u00ecnh b\u00e0y d\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u1ea1i h\u1ed9i ngh\u1ecb ASCO<\/li> <li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 76,10 USD - \u0110i\u1ec1u ch\u1ec9nh chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 79,60 USD - H\u1ee9ng kh\u1edfi khi tham gia ch\u01b0\u01a1ng tr\u00ecnh RTOR c\u1ee7a FDA<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 74,93 USD - L\u1ee3i nhu\u1eadn qu\u00fd 2 th\u1ea5p l\u00e0m gi\u1ea3m nhi\u1ec7t t\u00ecnh<\/li> <\/ul> <p>T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng? NUVL \u0111ang th\u1ef1c hi\u1ec7n chi\u1ebfn l\u01b0\u1ee3c \"OnTarget 2026\" v\u1edbi nhi\u1ec1u c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng. C\u00f4ng ty \u0111\u00e3 kh\u1edfi \u0111\u1ed9ng th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ALKAZAR so s\u00e1nh neladalkib v\u1edbi \u0111i\u1ec1u tr\u1ecb chu\u1ea9n alectinib, \u0111\u1ed3ng th\u1eddi ti\u1ebfn h\u00e0nh n\u1ed9p h\u1ed3 s\u01a1 NDA theo t\u1eebng ph\u1ea7n cho zidesamtinib.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 95-110 USD (ho\u00e0n t\u1ea5t n\u1ed9p h\u1ed3 s\u01a1 FDA v\u00e0 c\u00f4ng b\u1ed1 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li> <li><strong>2026<\/strong>: 130-160 USD (C\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t \u0111\u1ea7u ti\u00ean v\u00e0 ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i)<\/li> <li><strong>2028<\/strong>: 220-280 USD (Ra m\u1eaft nhi\u1ec1u s\u1ea3n ph\u1ea9m v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li> <li><strong>2030<\/strong>: 350-450 USD (Hi\u1ec7n di\u1ec7n th\u01b0\u01a1ng m\u1ea1i v\u1eefng ch\u1eafc v\u00e0 danh m\u1ee5c s\u1ea3n ph\u1ea9m tr\u01b0\u1edfng th\u00e0nh)<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn<\/strong>: NUVL l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111i\u1ec3n h\u00ecnh v\u1edbi r\u1ee7i ro cao v\u00e0 ph\u1ea7n th\u01b0\u1edfng l\u1edbn. V\u1edbi 13 nh\u00e0 ph\u00e2n t\u00edch duy tr\u00ec \u0111\u00e1nh gi\u00e1 mua v\u00e0 m\u1ee5c ti\u00eau gi\u00e1 t\u1eeb 100 \u0111\u1ebfn 140 USD (<a href=\"https:\/\/www.directorstalkinterviews.com\/nuvalent-inc-nuvl-stock-analysis-a-biotech-contender-with-52-potential-upside\/4121213505\">DirectorTalk Interviews<\/a>), s\u1ef1 \u0111\u1ed3ng thu\u1eadn cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng kho\u1ea3ng 52% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: B\u1ea5t k\u1ef3 trong ba \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a NUVL (NVL-520, NVL-655, NVL-330) c\u00f3 th\u1ec3 kh\u00f4ng \u0111\u1ea1t \u0111\u01b0\u1ee3c c\u00e1c ch\u1ec9 ti\u00eau hi\u1ec7u qu\u1ea3 ho\u1eb7c an to\u00e0n<\/li> <li><strong>FDA T\u1eeb Ch\u1ed1i<\/strong>: D\u00f9 \u0111\u00e3 n\u1ed9p h\u1ed3 s\u01a1 NDA theo t\u1eebng ph\u1ea7n, FDA c\u00f3 th\u1ec3 y\u00eau c\u1ea7u th\u00eam d\u1eef li\u1ec7u ho\u1eb7c nghi\u00ean c\u1ee9u<\/li> <li><strong>Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: D\u00f2ng ti\u1ec1n t\u1ef1 do \u00e2m -121 tri\u1ec7u USD \u0111\u00f2i h\u1ecfi qu\u1ea3n l\u00fd v\u1ed1n c\u1ea9n th\u1eadn<\/li> <li><strong>Bi\u1ebfn \u0110\u1ed9ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Beta 1,30 ngh\u0129a l\u00e0 bi\u1ebfn \u0111\u1ed9ng cao h\u01a1n 30% so v\u1edbi th\u1ecb tr\u01b0\u1eddng chung<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u Xanh Cho 2025-2026<\/h3> <ul> <li><strong>\u0110\u00e0 FDA<\/strong>: Tham gia ch\u01b0\u01a1ng tr\u00ecnh \u0110\u00e1nh Gi\u00e1 Ung Th\u01b0 Th\u1eddi Gian Th\u1ef1c gi\u00fap \u0111\u1ea9y nhanh ti\u1ebfn \u0111\u1ed9<\/li> <li><strong>\u0110\u1ed9 S\u00e2u Danh M\u1ee5c<\/strong>: Ba \u1ee9ng vi\u00ean giai \u0111o\u1ea1n l\u00e2m s\u00e0ng cung c\u1ea5p nhi\u1ec1u c\u01a1 h\u1ed9i th\u00e0nh c\u00f4ng<\/li> <li><strong>Nhu C\u1ea7u Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb l\u00e0 c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng tr\u00ean 15 t\u1ef7 USD<\/li> <li><strong>H\u1ed7 Tr\u1ee3 Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: \u0110\u00e1nh gi\u00e1 mua \u0111\u1ed3ng thu\u1eadn t\u1eeb 13 nh\u00e0 ph\u00e2n t\u00edch theo d\u00f5i<\/li> <li><strong>Ti\u1ec1n M\u1eb7t D\u1ef1 Tr\u1eef<\/strong>: V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 1 t\u1ef7 USD t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u0103m 2028<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 3-5% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 NUVL<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn, h\u00e3y mua t\u1eebng ph\u1ea7n nh\u1ecf trong v\u00e0i tu\u1ea7n<\/li> <li><strong>\u0110\u1eb7t C\u1ea3nh B\u00e1o Cho Ng\u00e0y 11 Th\u00e1ng 11<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn v\u00e0 s\u1eb5n s\u00e0ng h\u00e0nh \u0111\u1ed9ng khi c\u00f3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3<\/li> <li><strong>\u0110a D\u1ea1ng H\u00f3a<\/strong>: C\u00e2n b\u1eb1ng NUVL v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu ho\u1eb7c ETF ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe \u1ed5n \u0111\u1ecbnh h\u01a1n<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch NUVL gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y h\u1ecdc - \u0111\u1ea7y h\u1ed3i h\u1ed9p, \u0111\u00f4i khi g\u00e2y s\u1ed1c, nh\u01b0ng ph\u1ea7n k\u1ebft c\u00f3 th\u1ec3 r\u1ea5t ngo\u1ea1n m\u1ee5c!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Nuvalent, Inc. (NUVL) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i c\u00f3 th\u1ec3 m\u1ea5t<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"NUVL\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm \"Nuvalent\"<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 mua v\u00e0o<\/td><\/tr> <tr><td>5<\/td><td>Xem L\u1ea1i v\u00e0 X\u00e1c Nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng - n\u00ean d\u01b0\u1edbi 1% gi\u00e1 tr\u1ecb giao d\u1ecbch<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td><td>Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng nh\u01b0 h\u1ed7 tr\u1ee3 70 USD v\u00e0 kh\u00e1ng c\u1ef1 80 USD<\/td><\/tr> <tr><td>7<\/td><td>L\u1eadp K\u1ebf Ho\u1ea1ch Tho\u00e1t L\u1ec7nh<\/td><td>Quy\u1ebft \u0111\u1ecbnh tr\u01b0\u1edbc khi b\u1ea1n s\u1ebd ch\u1ed1t l\u1eddi ho\u1eb7c c\u1eaft l\u1ed7<\/td><\/tr> <tr><td>8<\/td><td>Ghi L\u1ea1i L\u00fd Do \u0110\u1ea7u T\u01b0<\/td><td>Vi\u1ebft ra l\u00fd do mua \u0111\u1ec3 tr\u00e1nh quy\u1ebft \u0111\u1ecbnh c\u1ea3m t\u00ednh sau n\u00e0y<\/td><\/tr> <tr><td>9<\/td><td>Theo D\u00f5i Tin T\u1ee9c C\u00f4ng Ty<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o Google cho \"Nuvalent\" v\u00e0 \"NVL-520\"<\/td><\/tr> <tr><td>10<\/td><td>\u0110\u00e1nh Gi\u00e1 L\u1ea1i H\u00e0ng Qu\u00fd<\/td><td>\u0110\u00e1nh gi\u00e1 l\u1ea1i kho\u1ea3n \u0111\u1ea7u t\u01b0 sau m\u1ed7i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi NUVL<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n \u0111\u1ea7u t\u01b0 v\u00e0o c\u00e1c c\u00f4ng ty \u0111\u1ed5i m\u1edbi nh\u01b0 Nuvalent, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi:<\/p> <ul> <li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> - B\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf \u0111\u1ec3 th\u1eed nghi\u1ec7m lu\u1eadn \u0111i\u1ec3m \u0111\u1ea7u t\u01b0 tr\u01b0\u1edbc khi cam k\u1ebft v\u1ed1n l\u1edbn. \u0110i\u1ec1u n\u00e0y r\u1ea5t quan tr\u1ecdng v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 NUVL, n\u01a1i b\u1ea1n c\u00f3 th\u1ec3 mu\u1ed1n th\u1eed nghi\u1ec7m d\u1ea7n d\u1ea7n.<\/li> <li><strong>X\u00e1c Minh Nhanh Ch\u00f3ng<\/strong> - Ho\u00e0n th\u00e0nh KYC trong ch\u01b0a \u0111\u1ea7y m\u1ed9t ph\u00fat v\u1edbi b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd n\u00e0o. Khi c\u00f3 c\u01a1 h\u1ed9i nh\u1ea1y c\u1ea3m v\u1ec1 th\u1eddi gian quanh k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng ho\u1eb7c th\u00f4ng b\u00e1o FDA, b\u1ea1n s\u1ebd kh\u00f4ng b\u1ecf l\u1ee1 do quy tr\u00ecnh ph\u00ea duy\u1ec7t k\u00e9o d\u00e0i.<\/li> <li><strong>H\u01a1n 100 Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong> - T\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng, b\u1ea1n c\u00f3 s\u1ef1 linh ho\u1ea1t trong c\u00e1ch ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn khi ti\u1ec1m n\u0103ng c\u1ee7a NUVL \u0111\u01b0\u1ee3c hi\u1ec7n th\u1ef1c h\u00f3a.<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c theo d\u00f5i v\u1ecb th\u1ebf NUVL c\u1ee7a b\u1ea1n tr\u1edf n\u00ean \u0111\u01a1n gi\u1ea3n, v\u1edbi bi\u1ec3u \u0111\u1ed3 th\u1eddi gian th\u1ef1c v\u00e0 t\u00edch h\u1ee3p tin t\u1ee9c gi\u00fap b\u1ea1n lu\u00f4n c\u1eadp nh\u1eadt c\u00e1c di\u1ec5n bi\u1ebfn quan tr\u1ecdng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn kho\u1ea3n \u0111\u1ea7u t\u01b0.<\/p> <h2>\ud83c\udf0d Nuvalent N\u0103m 2025: Ti\u00ean Phong Trong Ung Th\u01b0 Ch\u00ednh X\u00e1c<\/h2> <p>Nuvalent \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng trong \u0111i\u1ec1u tr\u1ecb ung th\u01b0. C\u00f4ng ty kh\u00f4ng ch\u1ec9 ph\u00e1t tri\u1ec3n m\u1ed9t lo\u1ea1i thu\u1ed1c h\u00f3a tr\u1ecb m\u1edbi - h\u1ecd t\u1ea1o ra c\u00e1c li\u1ec7u ph\u00e1p nh\u1eafm m\u1ee5c ti\u00eau ch\u00ednh x\u00e1c nh\u1eb1m v\u01b0\u1ee3t qua nh\u1eefng h\u1ea1n ch\u1ebf c\u1ee7a c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb hi\u1ec7n c\u00f3. T\u1eadp trung v\u00e0o c\u00e1c kinase trong c\u00e1c lo\u1ea1i ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb, h\u1ecd gi\u1ea3i quy\u1ebft m\u1ed9t trong nh\u1eefng nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn nh\u1ea5t trong l\u0129nh v\u1ef1c ung th\u01b0 h\u1ecdc.<\/p> <p>V\u1edbi 162 nh\u00e2n vi\u00ean v\u00e0 ho\u1ea1t \u0111\u1ed9ng t\u1ea1i Cambridge, Massachusetts, Nuvalent duy tr\u00ec s\u1ef1 linh ho\u1ea1t c\u1ee7a m\u1ed9t startup trong khi theo \u0111u\u1ed5i c\u00e1c ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng tham v\u1ecdng c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u0103m s\u00f3c ung th\u01b0. C\u00e1c \u1ee9ng vi\u00ean s\u1ea3n ph\u1ea9m h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty nh\u1eafm v\u00e0o NSCLC d\u01b0\u01a1ng t\u00ednh ROS1, NSCLC d\u01b0\u01a1ng t\u00ednh ALK v\u00e0 c\u00e1c lo\u1ea1i ung th\u01b0 bi\u1ebfn \u0111\u1ed5i HER2 - nh\u1eefng l\u0129nh v\u1ef1c m\u00e0 c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb hi\u1ec7n t\u1ea1i th\u01b0\u1eddng th\u1ea5t b\u1ea1i do c\u01a1 ch\u1ebf kh\u00e1ng thu\u1ed1c.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Nuvalent \u0111\u00e3 c\u00f4ng b\u1ed1 nghi\u00ean c\u1ee9u \u0111\u1ed9t ph\u00e1 tr\u00ean t\u1ea1p ch\u00ed Molecular Cancer Therapeutics ch\u1ee9ng minh c\u00e1ch ti\u1ebfp c\u1eadn thi\u1ebft k\u1ebf ph\u00e2n t\u1eed h\u1ee3p l\u00fd c\u1ee7a h\u1ecd \u0111\u00e3 t\u1ea1o ra zidesamtinib nh\u01b0 m\u1ed9t ch\u1ea5t \u1ee9c ch\u1ebf ch\u1ecdn l\u1ecdc ROS1 m\u1edbi (<a href=\"https:\/\/investors.nuvalent.com\/2025-04-29-Nuvalent-Announces-Publication-in-Molecular-Cancer-Therapeutics-Reinforcing-Rational-Molecular-Design-of-Zidesamtinib-as-a-Novel-ROS1-Selective-Inhibitor\">Th\u00f4ng B\u00e1o C\u00f4ng Ty<\/a>). \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t b\u00e0i b\u00e1o h\u1ecdc thu\u1eadt - n\u00f3 tr\u00ecnh b\u00e0y khoa h\u1ecdc \u0111\u1eb1ng sau m\u1ed9t li\u1ec7u ph\u00e1p ung th\u01b0 c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh h\u00e0ng \u0111\u1ea7u trong ph\u00e2n kh\u00fac.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Nuvalent: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 30 th\u00e1ng 8 n\u0103m 2025, Nuvalent, Inc. (NUVL) giao d\u1ecbch \u1edf m\u1ee9c <strong>74,93 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu tr\u00ean s\u00e0n NASDAQ. C\u1ed5 phi\u1ebfu n\u00e0y \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3, \u0111i\u1ec3n h\u00ecnh cho c\u00e1c c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng, v\u1edbi ph\u1ea1m vi 52 tu\u1ea7n t\u1eeb 55,54 USD \u0111\u1ebfn 113,51 USD &#8211; ch\u00eanh l\u1ec7ch h\u01a1n 100% gi\u1eefa m\u1ee9c th\u1ea5p v\u00e0 cao!<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 NUVL. \u0110\u00e2y l\u00e0 th\u1eddi \u0111i\u1ec3m c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3 n\u0103m 2025, v\u00e0 d\u1ef1a tr\u00ean c\u00e1c m\u1eabu l\u1ecbch s\u1eed, c\u00e1c b\u00e1o c\u00e1o n\u00e0y c\u00f3 th\u1ec3 l\u00e0m bi\u1ebfn \u0111\u1ed9ng gi\u00e1 c\u1ed5 phi\u1ebfu m\u1ea1nh m\u1ebd.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o L\u1ee3i Nhu\u1eadn \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu NUVL<\/h3>\n<p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y cho th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng v\u1ec1 c\u00e1c bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3 quanh c\u00e1c th\u00f4ng b\u00e1o quan tr\u1ecdng:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>7 th\u00e1ng 8, 2025<\/td>\n<td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2<\/td>\n<td>78,50 USD<\/td>\n<td>-4,5% (b\u1ecf l\u1ee1 \u01b0\u1edbc t\u00ednh EPS)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 5, 2025<\/td>\n<td>C\u1eadp Nh\u1eadt Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/td>\n<td>72,30 USD<\/td>\n<td>+18,2% (d\u1eef li\u1ec7u t\u00edch c\u1ef1c)<\/td>\n<\/tr>\n<tr>\n<td>27 th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft Qu\u1ea3 Qu\u00fd 4 n\u0103m 2024<\/td>\n<td>68,90 USD<\/td>\n<td>+9,8% (ti\u1ebfn tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m)<\/td>\n<\/tr>\n<tr>\n<td>9 th\u00e1ng 11, 2024<\/td>\n<td>Tin N\u1ed9p H\u1ed3 S\u01a1 FDA<\/td>\n<td>65,40 USD<\/td>\n<td>+22,1% (ch\u1ea5p nh\u1eadn NDA theo t\u1eebng ph\u1ea7n)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 8, 2024<\/td>\n<td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2 n\u0103m 2024<\/td>\n<td>62,10 USD<\/td>\n<td>+11,3% (c\u1eadp nh\u1eadt danh m\u1ee5c m\u1ea1nh m\u1ebd)<\/td>\n<\/tr>\n<tr>\n<td>10 th\u00e1ng 5, 2024<\/td>\n<td>D\u1eef Li\u1ec7u Giai \u0110o\u1ea1n 1<\/td>\n<td>58,20 USD<\/td>\n<td>+6,8% (k\u1ebft qu\u1ea3 kh\u00edch l\u1ec7)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: C\u00e1c c\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c v\u1ec1 quy \u0111\u1ecbnh th\u01b0\u1eddng th\u00fac \u0111\u1ea9y m\u1ee9c t\u0103ng l\u1edbn nh\u1ea5t (18-22%), trong khi vi\u1ec7c b\u1ecf l\u1ee1 l\u1ee3i nhu\u1eadn g\u00e2y ra c\u00e1c \u0111\u1ee3t gi\u1ea3m t\u1ea1m th\u1eddi kho\u1ea3ng 4-5%. M\u00f4 h\u00ecnh n\u00e0y cho th\u1ea5y c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 NUVL n\u00ean t\u1eadp trung nhi\u1ec1u h\u01a1n v\u00e0o c\u00e1c ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng thay v\u00ec c\u00e1c b\u00e1o c\u00e1o t\u00e0i ch\u00ednh h\u00e0ng qu\u00fd.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h2>\n<p>C\u1ed5 phi\u1ebfu Nuvalent \u0111\u00e3 t\u0103ng <strong>27,8%<\/strong> trong s\u00e1u th\u00e1ng qua, nh\u01b0ng h\u00e0nh tr\u00ecnh kh\u00f4ng h\u1ec1 su\u00f4n s\u1ebb:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 62,50 USD &#8211; Giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 sau k\u1ef3 ngh\u1ec9 l\u1ec5<\/li>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 71,80 USD &#8211; T\u0103ng gi\u00e1 khi b\u1eaft \u0111\u1ea7u th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ALKAZAR<\/li>\n<li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 68,20 USD &#8211; Ch\u1ed1t l\u1eddi sau \u0111\u1ee3t t\u0103ng th\u00e1ng 3<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 83,40 USD &#8211; Tr\u00ecnh b\u00e0y d\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u1ea1i h\u1ed9i ngh\u1ecb ASCO<\/li>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 76,10 USD &#8211; \u0110i\u1ec1u ch\u1ec9nh chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 79,60 USD &#8211; H\u1ee9ng kh\u1edfi khi tham gia ch\u01b0\u01a1ng tr\u00ecnh RTOR c\u1ee7a FDA<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 74,93 USD &#8211; L\u1ee3i nhu\u1eadn qu\u00fd 2 th\u1ea5p l\u00e0m gi\u1ea3m nhi\u1ec7t t\u00ecnh<\/li>\n<\/ul>\n<p>T\u1ea1i sao l\u1ea1i bi\u1ebfn \u0111\u1ed9ng? NUVL \u0111ang th\u1ef1c hi\u1ec7n chi\u1ebfn l\u01b0\u1ee3c &#8220;OnTarget 2026&#8221; v\u1edbi nhi\u1ec1u c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng. C\u00f4ng ty \u0111\u00e3 kh\u1edfi \u0111\u1ed9ng th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ALKAZAR so s\u00e1nh neladalkib v\u1edbi \u0111i\u1ec1u tr\u1ecb chu\u1ea9n alectinib, \u0111\u1ed3ng th\u1eddi ti\u1ebfn h\u00e0nh n\u1ed9p h\u1ed3 s\u01a1 NDA theo t\u1eebng ph\u1ea7n cho zidesamtinib.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tri\u1ec3n danh m\u1ee5c s\u1ea3n ph\u1ea9m, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 95-110 USD (ho\u00e0n t\u1ea5t n\u1ed9p h\u1ed3 s\u01a1 FDA v\u00e0 c\u00f4ng b\u1ed1 d\u1eef li\u1ec7u l\u00e2m s\u00e0ng) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li>\n<li><strong>2026<\/strong>: 130-160 USD (C\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t \u0111\u1ea7u ti\u00ean v\u00e0 ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i)<\/li>\n<li><strong>2028<\/strong>: 220-280 USD (Ra m\u1eaft nhi\u1ec1u s\u1ea3n ph\u1ea9m v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li>\n<li><strong>2030<\/strong>: 350-450 USD (Hi\u1ec7n di\u1ec7n th\u01b0\u01a1ng m\u1ea1i v\u1eefng ch\u1eafc v\u00e0 danh m\u1ee5c s\u1ea3n ph\u1ea9m tr\u01b0\u1edfng th\u00e0nh)<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: NUVL l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111i\u1ec3n h\u00ecnh v\u1edbi r\u1ee7i ro cao v\u00e0 ph\u1ea7n th\u01b0\u1edfng l\u1edbn. V\u1edbi 13 nh\u00e0 ph\u00e2n t\u00edch duy tr\u00ec \u0111\u00e1nh gi\u00e1 mua v\u00e0 m\u1ee5c ti\u00eau gi\u00e1 t\u1eeb 100 \u0111\u1ebfn 140 USD (<a href=\"https:\/\/www.directorstalkinterviews.com\/nuvalent-inc-nuvl-stock-analysis-a-biotech-contender-with-52-potential-upside\/4121213505\">DirectorTalk Interviews<\/a>), s\u1ef1 \u0111\u1ed3ng thu\u1eadn cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng kho\u1ea3ng 52% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: B\u1ea5t k\u1ef3 trong ba \u1ee9ng vi\u00ean h\u00e0ng \u0111\u1ea7u c\u1ee7a NUVL (NVL-520, NVL-655, NVL-330) c\u00f3 th\u1ec3 kh\u00f4ng \u0111\u1ea1t \u0111\u01b0\u1ee3c c\u00e1c ch\u1ec9 ti\u00eau hi\u1ec7u qu\u1ea3 ho\u1eb7c an to\u00e0n<\/li>\n<li><strong>FDA T\u1eeb Ch\u1ed1i<\/strong>: D\u00f9 \u0111\u00e3 n\u1ed9p h\u1ed3 s\u01a1 NDA theo t\u1eebng ph\u1ea7n, FDA c\u00f3 th\u1ec3 y\u00eau c\u1ea7u th\u00eam d\u1eef li\u1ec7u ho\u1eb7c nghi\u00ean c\u1ee9u<\/li>\n<li><strong>Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: D\u00f2ng ti\u1ec1n t\u1ef1 do \u00e2m -121 tri\u1ec7u USD \u0111\u00f2i h\u1ecfi qu\u1ea3n l\u00fd v\u1ed1n c\u1ea9n th\u1eadn<\/li>\n<li><strong>Bi\u1ebfn \u0110\u1ed9ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Beta 1,30 ngh\u0129a l\u00e0 bi\u1ebfn \u0111\u1ed9ng cao h\u01a1n 30% so v\u1edbi th\u1ecb tr\u01b0\u1eddng chung<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u Xanh Cho 2025-2026<\/h3>\n<ul>\n<li><strong>\u0110\u00e0 FDA<\/strong>: Tham gia ch\u01b0\u01a1ng tr\u00ecnh \u0110\u00e1nh Gi\u00e1 Ung Th\u01b0 Th\u1eddi Gian Th\u1ef1c gi\u00fap \u0111\u1ea9y nhanh ti\u1ebfn \u0111\u1ed9<\/li>\n<li><strong>\u0110\u1ed9 S\u00e2u Danh M\u1ee5c<\/strong>: Ba \u1ee9ng vi\u00ean giai \u0111o\u1ea1n l\u00e2m s\u00e0ng cung c\u1ea5p nhi\u1ec1u c\u01a1 h\u1ed9i th\u00e0nh c\u00f4ng<\/li>\n<li><strong>Nhu C\u1ea7u Th\u1ecb Tr\u01b0\u1eddng<\/strong>: Ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb l\u00e0 c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng tr\u00ean 15 t\u1ef7 USD<\/li>\n<li><strong>H\u1ed7 Tr\u1ee3 Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: \u0110\u00e1nh gi\u00e1 mua \u0111\u1ed3ng thu\u1eadn t\u1eeb 13 nh\u00e0 ph\u00e2n t\u00edch theo d\u00f5i<\/li>\n<li><strong>Ti\u1ec1n M\u1eb7t D\u1ef1 Tr\u1eef<\/strong>: V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 1 t\u1ef7 USD t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u0103m 2028<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 3-5% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 NUVL<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn, h\u00e3y mua t\u1eebng ph\u1ea7n nh\u1ecf trong v\u00e0i tu\u1ea7n<\/li>\n<li><strong>\u0110\u1eb7t C\u1ea3nh B\u00e1o Cho Ng\u00e0y 11 Th\u00e1ng 11<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y c\u00f4ng b\u1ed1 l\u1ee3i nhu\u1eadn v\u00e0 s\u1eb5n s\u00e0ng h\u00e0nh \u0111\u1ed9ng khi c\u00f3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3<\/li>\n<li><strong>\u0110a D\u1ea1ng H\u00f3a<\/strong>: C\u00e2n b\u1eb1ng NUVL v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu ho\u1eb7c ETF ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe \u1ed5n \u0111\u1ecbnh h\u01a1n<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch NUVL gi\u1ed1ng nh\u01b0 xem m\u1ed9t b\u1ed9 phim y h\u1ecdc &#8211; \u0111\u1ea7y h\u1ed3i h\u1ed9p, \u0111\u00f4i khi g\u00e2y s\u1ed1c, nh\u01b0ng ph\u1ea7n k\u1ebft c\u00f3 th\u1ec3 r\u1ea5t ngo\u1ea1n m\u1ee5c!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Nuvalent, Inc. (NUVL) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i c\u00f3 th\u1ec3 m\u1ea5t<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;NUVL&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm &#8220;Nuvalent&#8221;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 mua v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem L\u1ea1i v\u00e0 X\u00e1c Nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng &#8211; n\u00ean d\u01b0\u1edbi 1% gi\u00e1 tr\u1ecb giao d\u1ecbch<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td>\n<td>Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng nh\u01b0 h\u1ed7 tr\u1ee3 70 USD v\u00e0 kh\u00e1ng c\u1ef1 80 USD<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>L\u1eadp K\u1ebf Ho\u1ea1ch Tho\u00e1t L\u1ec7nh<\/td>\n<td>Quy\u1ebft \u0111\u1ecbnh tr\u01b0\u1edbc khi b\u1ea1n s\u1ebd ch\u1ed1t l\u1eddi ho\u1eb7c c\u1eaft l\u1ed7<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Ghi L\u1ea1i L\u00fd Do \u0110\u1ea7u T\u01b0<\/td>\n<td>Vi\u1ebft ra l\u00fd do mua \u0111\u1ec3 tr\u00e1nh quy\u1ebft \u0111\u1ecbnh c\u1ea3m t\u00ednh sau n\u00e0y<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Theo D\u00f5i Tin T\u1ee9c C\u00f4ng Ty<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o Google cho &#8220;Nuvalent&#8221; v\u00e0 &#8220;NVL-520&#8221;<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0110\u00e1nh Gi\u00e1 L\u1ea1i H\u00e0ng Qu\u00fd<\/td>\n<td>\u0110\u00e1nh gi\u00e1 l\u1ea1i kho\u1ea3n \u0111\u1ea7u t\u01b0 sau m\u1ed7i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi NUVL<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n \u0111\u1ea7u t\u01b0 v\u00e0o c\u00e1c c\u00f4ng ty \u0111\u1ed5i m\u1edbi nh\u01b0 Nuvalent, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi:<\/p>\n<ul>\n<li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> &#8211; B\u1ea1n c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf \u0111\u1ec3 th\u1eed nghi\u1ec7m lu\u1eadn \u0111i\u1ec3m \u0111\u1ea7u t\u01b0 tr\u01b0\u1edbc khi cam k\u1ebft v\u1ed1n l\u1edbn. \u0110i\u1ec1u n\u00e0y r\u1ea5t quan tr\u1ecdng v\u1edbi c\u00e1c c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 NUVL, n\u01a1i b\u1ea1n c\u00f3 th\u1ec3 mu\u1ed1n th\u1eed nghi\u1ec7m d\u1ea7n d\u1ea7n.<\/li>\n<li><strong>X\u00e1c Minh Nhanh Ch\u00f3ng<\/strong> &#8211; Ho\u00e0n th\u00e0nh KYC trong ch\u01b0a \u0111\u1ea7y m\u1ed9t ph\u00fat v\u1edbi b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd n\u00e0o. Khi c\u00f3 c\u01a1 h\u1ed9i nh\u1ea1y c\u1ea3m v\u1ec1 th\u1eddi gian quanh k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng ho\u1eb7c th\u00f4ng b\u00e1o FDA, b\u1ea1n s\u1ebd kh\u00f4ng b\u1ecf l\u1ee1 do quy tr\u00ecnh ph\u00ea duy\u1ec7t k\u00e9o d\u00e0i.<\/li>\n<li><strong>H\u01a1n 100 Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong> &#8211; T\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng, b\u1ea1n c\u00f3 s\u1ef1 linh ho\u1ea1t trong c\u00e1ch ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn khi ti\u1ec1m n\u0103ng c\u1ee7a NUVL \u0111\u01b0\u1ee3c hi\u1ec7n th\u1ef1c h\u00f3a.<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap vi\u1ec7c theo d\u00f5i v\u1ecb th\u1ebf NUVL c\u1ee7a b\u1ea1n tr\u1edf n\u00ean \u0111\u01a1n gi\u1ea3n, v\u1edbi bi\u1ec3u \u0111\u1ed3 th\u1eddi gian th\u1ef1c v\u00e0 t\u00edch h\u1ee3p tin t\u1ee9c gi\u00fap b\u1ea1n lu\u00f4n c\u1eadp nh\u1eadt c\u00e1c di\u1ec5n bi\u1ebfn quan tr\u1ecdng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn kho\u1ea3n \u0111\u1ea7u t\u01b0.<\/p>\n<h2>\ud83c\udf0d Nuvalent N\u0103m 2025: Ti\u00ean Phong Trong Ung Th\u01b0 Ch\u00ednh X\u00e1c<\/h2>\n<p>Nuvalent \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng trong \u0111i\u1ec1u tr\u1ecb ung th\u01b0. C\u00f4ng ty kh\u00f4ng ch\u1ec9 ph\u00e1t tri\u1ec3n m\u1ed9t lo\u1ea1i thu\u1ed1c h\u00f3a tr\u1ecb m\u1edbi &#8211; h\u1ecd t\u1ea1o ra c\u00e1c li\u1ec7u ph\u00e1p nh\u1eafm m\u1ee5c ti\u00eau ch\u00ednh x\u00e1c nh\u1eb1m v\u01b0\u1ee3t qua nh\u1eefng h\u1ea1n ch\u1ebf c\u1ee7a c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb hi\u1ec7n c\u00f3. T\u1eadp trung v\u00e0o c\u00e1c kinase trong c\u00e1c lo\u1ea1i ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb, h\u1ecd gi\u1ea3i quy\u1ebft m\u1ed9t trong nh\u1eefng nhu c\u1ea7u y t\u1ebf ch\u01b0a \u0111\u01b0\u1ee3c \u0111\u00e1p \u1ee9ng l\u1edbn nh\u1ea5t trong l\u0129nh v\u1ef1c ung th\u01b0 h\u1ecdc.<\/p>\n<p>V\u1edbi 162 nh\u00e2n vi\u00ean v\u00e0 ho\u1ea1t \u0111\u1ed9ng t\u1ea1i Cambridge, Massachusetts, Nuvalent duy tr\u00ec s\u1ef1 linh ho\u1ea1t c\u1ee7a m\u1ed9t startup trong khi theo \u0111u\u1ed5i c\u00e1c ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng tham v\u1ecdng c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u00e1ch ch\u0103m s\u00f3c ung th\u01b0. C\u00e1c \u1ee9ng vi\u00ean s\u1ea3n ph\u1ea9m h\u00e0ng \u0111\u1ea7u c\u1ee7a c\u00f4ng ty nh\u1eafm v\u00e0o NSCLC d\u01b0\u01a1ng t\u00ednh ROS1, NSCLC d\u01b0\u01a1ng t\u00ednh ALK v\u00e0 c\u00e1c lo\u1ea1i ung th\u01b0 bi\u1ebfn \u0111\u1ed5i HER2 &#8211; nh\u1eefng l\u0129nh v\u1ef1c m\u00e0 c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb hi\u1ec7n t\u1ea1i th\u01b0\u1eddng th\u1ea5t b\u1ea1i do c\u01a1 ch\u1ebf kh\u00e1ng thu\u1ed1c.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: C\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Nuvalent \u0111\u00e3 c\u00f4ng b\u1ed1 nghi\u00ean c\u1ee9u \u0111\u1ed9t ph\u00e1 tr\u00ean t\u1ea1p ch\u00ed Molecular Cancer Therapeutics ch\u1ee9ng minh c\u00e1ch ti\u1ebfp c\u1eadn thi\u1ebft k\u1ebf ph\u00e2n t\u1eed h\u1ee3p l\u00fd c\u1ee7a h\u1ecd \u0111\u00e3 t\u1ea1o ra zidesamtinib nh\u01b0 m\u1ed9t ch\u1ea5t \u1ee9c ch\u1ebf ch\u1ecdn l\u1ecdc ROS1 m\u1edbi (<a href=\"https:\/\/investors.nuvalent.com\/2025-04-29-Nuvalent-Announces-Publication-in-Molecular-Cancer-Therapeutics-Reinforcing-Rational-Molecular-Design-of-Zidesamtinib-as-a-Novel-ROS1-Selective-Inhibitor\">Th\u00f4ng B\u00e1o C\u00f4ng Ty<\/a>). \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t b\u00e0i b\u00e1o h\u1ecdc thu\u1eadt &#8211; n\u00f3 tr\u00ecnh b\u00e0y khoa h\u1ecdc \u0111\u1eb1ng sau m\u1ed9t li\u1ec7u ph\u00e1p ung th\u01b0 c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh h\u00e0ng \u0111\u1ea7u trong ph\u00e2n kh\u00fac.<\/p>\n"},"faq":[{"question":"Nuvalent, Inc. (NUVL) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Nuvalent, Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng t\u1eadp trung v\u00e0o ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ch\u00ednh x\u00e1c, \u0111\u1eb7c bi\u1ec7t nh\u1eafm v\u00e0o c\u00e1c lo\u1ea1i ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu NUVL?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu NUVL th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ, s\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n \"NUVL\" v\u00e0 th\u1ef1c hi\u1ec7n c\u00e1c b\u01b0\u1edbc nh\u01b0 ch\u1ecdn n\u1ec1n t\u1ea3ng, n\u1ea1p ti\u1ec1n, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o NUVL l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t, ti\u00eau hao ti\u1ec1n m\u1eb7t l\u1edbn v\u00e0 bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng cao h\u01a1n m\u1ee9c trung b\u00ecnh."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a NUVL trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i, gi\u00e1 c\u1ed5 phi\u1ebfu NUVL c\u00f3 th\u1ec3 t\u0103ng l\u00ean 95-110 USD v\u00e0o cu\u1ed1i n\u0103m 2025, v\u00e0 ti\u1ebfp t\u1ee5c t\u0103ng l\u00ean 350-450 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c s\u1ea3n ph\u1ea9m \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u01b0\u01a1ng m\u1ea1i h\u00f3a th\u00e0nh c\u00f4ng."},{"question":"Nh\u1eefng l\u1eddi khuy\u00ean n\u00e0o d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi khi mua c\u1ed5 phi\u1ebfu NUVL?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf (3-5% danh m\u1ee5c), \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 \u0111\u00f4 la, \u0111\u1eb7t c\u1ea3nh b\u00e1o cho c\u00e1c ng\u00e0y c\u00f4ng b\u1ed1 quan tr\u1ecdng, v\u00e0 \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c \u0111\u1ea7u t\u01b0 \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Nuvalent, Inc. (NUVL) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Nuvalent, Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng t\u1eadp trung v\u00e0o ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb ung th\u01b0 ch\u00ednh x\u00e1c, \u0111\u1eb7c bi\u1ec7t nh\u1eafm v\u00e0o c\u00e1c lo\u1ea1i ung th\u01b0 kh\u00e1ng \u0111i\u1ec1u tr\u1ecb."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu NUVL?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu NUVL th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n cung c\u1ea5p c\u1ed5 phi\u1ebfu ni\u00eam y\u1ebft tr\u00ean NASDAQ, s\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n \"NUVL\" v\u00e0 th\u1ef1c hi\u1ec7n c\u00e1c b\u01b0\u1edbc nh\u01b0 ch\u1ecdn n\u1ec1n t\u1ea3ng, n\u1ea1p ti\u1ec1n, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o NUVL l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t, ti\u00eau hao ti\u1ec1n m\u1eb7t l\u1edbn v\u00e0 bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng cao h\u01a1n m\u1ee9c trung b\u00ecnh."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a NUVL trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i, gi\u00e1 c\u1ed5 phi\u1ebfu NUVL c\u00f3 th\u1ec3 t\u0103ng l\u00ean 95-110 USD v\u00e0o cu\u1ed1i n\u0103m 2025, v\u00e0 ti\u1ebfp t\u1ee5c t\u0103ng l\u00ean 350-450 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c s\u1ea3n ph\u1ea9m \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 th\u01b0\u01a1ng m\u1ea1i h\u00f3a th\u00e0nh c\u00f4ng."},{"question":"Nh\u1eefng l\u1eddi khuy\u00ean n\u00e0o d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi khi mua c\u1ed5 phi\u1ebfu NUVL?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf (3-5% danh m\u1ee5c), \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 \u0111\u00f4 la, \u0111\u1eb7t c\u1ea3nh b\u00e1o cho c\u00e1c ng\u00e0y c\u00f4ng b\u1ed1 quan tr\u1ecdng, v\u00e0 \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c \u0111\u1ea7u t\u01b0 \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T08:48:13+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)\",\"datePublished\":\"2025-08-30T08:48:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-30T08:48:13+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T08:48:13+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)","datePublished":"2025-08-30T08:48:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-30T08:48:13+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-nuvalent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Nuvalent, Inc. (NUVL)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":359326,"slug":"how-to-buy-nuvalent","post_title":"Como comprar a\u00e7\u00f5es da Nuvalent, Inc. (NUVL) - Investimento em a\u00e7\u00f5es da Nuvalent, Inc. (NUVL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-nuvalent\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/359330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=359330"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/359330\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=359330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=359330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=359330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}